Traditional vaccines work by stimulating the immune system, but their effectiveness is often limited by how well they can ...
Desjardins analyst A. Leon anticipates that the company will earn $0.01 per share for the quarter. Desjardins also issued ...
The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...
Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...
2d
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...
The low-cost test developed by Professor Vinayak Dravid and research professor Gajendra Shekhawat builds on an existing ...
In recent years, the familiar symptoms of the flu might kick us into reaching for at-home testing kits. But on the eve of the ...
Equities researchers at HC Wainwright issued their Q4 2025 earnings estimates for Nkarta in a note issued to investors on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback